Patent Assignment
Reel/Frame 063848/0209
Security Interest
Recorded: 2023-06-04
Pages: 7
Assignee
ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
601 LEXINGTON AVENUE, 54TH FLOOR, C/O ORBIMED ADVISORS LLC, NEW YORK, NEW YORK, 10022
Covered Properties
(6)
Compositions and Methods for the Treatment of Opioid Overdose
Application:
17/881,191 →
Publication:
US US20220387306A1
Administration of Benzodiazepine Compositions
Application:
18/062,062 →
Publication:
US US20230104144A1
Intranasal Olanzapine Formulations and Methods of Their Use
Methods and Compositions for Treating Seizure Disorders in Pediatric Patients
Polymorphs of Substituted Isoquinoline-Based Rho Kinase Inhibitors
Application:
63/350,936 →
Compositions and Methods for the Treatment of Opioid Overdose
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 7, 2019
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 050639/0392 →
Assignment of Assignor's Interest
Oct 7, 2019
From: CRYSTAL, ROGER
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 050642/0976 →
Assignment of Assignor's Interest
Oct 7, 2019
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 050642/0358 →
Assignment of Assignor's Interest
Oct 7, 2019
From: CRYSTAL, ROGER
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 050639/0758 →
Security Interest
Aug 6, 2021
From: NEURELIS, INC.; AEGIS THERAPEUTICS, LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 057111/0242 →
Assignment of Assignor's Interest
Aug 4, 2022
From: CRYSTAL, ROGER
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 060723/0046 →
Assignment of Assignor's Interest
Aug 4, 2022
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 060723/0089 →
Assignment of Assignor's Interest
Oct 13, 2022
From: RABINOWICZ, ADRIAN L.
To: NEURELIS, INC.
Reel/Frame 061417/0260 →
Assignment of Assignor's Interest
Oct 13, 2022
From: CARRAZANA, ENRIQUE J.
To: NEURELIS, INC.
Reel/Frame 061417/0315 →
Assignment of Assignor's Interest
Oct 13, 2022
From: MADDEN, STUART
To: NEURELIS, INC.
Reel/Frame 061417/0446 →
Assignment of Assignor's Interest
Nov 4, 2022
From: ROSEN, KENNETH M.; ABBINANTI, MATTHEW D.; MCKERRACHER, LISA
To: BIOAXONE BIOSCIENCES, INC.
Reel/Frame 061661/0503 →
Assignment of Assignor's Interest
Dec 6, 2022
From: CARTT, STEVE; MEDEIROS, DAVID; GWOZDZ, GARRY THOMAS; LOXLEY, ANDREW
To: HALE BIOPHARMA VENTURES, LLC
Reel/Frame 061989/0519 →
Assignment of Assignor's Interest
Dec 6, 2022
From: HALE BIOPHARMA VENTURES, LLC
To: NEURELIS, INC.
Reel/Frame 061989/0565 →
Assignment of Assignor's Interest
Apr 5, 2023
From: MADDEN, STUART
To: NEURELIS, INC.
Reel/Frame 063233/0605 →
Merger
Jun 13, 2023
From: OPIANT PHARMACEUTICALS, INC.
To: INDIVIOR INC.
Reel/Frame 063931/0392 →
Security Interest
Nov 13, 2024
From: INDIVIOR INC.; INDIVIOR UK LIMITED
To: PIPER SANDLER FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 069254/0413 →
Release of Security Interest
Nov 14, 2024
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: NEURELIS, INC.; AEGIS THERAPEUTICS, LLC
Reel/Frame 069359/0921 →
Assignment of Assignor's Interest
May 30, 2025
From: AEGIS THERAPEUTICS, LLC
To: INDIVIOR INC.
Reel/Frame 071261/0260 →
Release of Security Interest
Mar 18, 2026
From: PIPER SANDLER FINANCE, LLC
To: INDIVIOR INC.; INDIVIOR UK LIMITED
Reel/Frame 074114/0582 →